Clinical Trials Directory

Trials / Unknown

UnknownNCT03377946

Effect of Probiotics on Pre-diabetes and Diabetes in China

Effect of Probiotics on Pre-diabetes and Diabetes in China-the Role of Gut Microbiota Composition

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
220 (estimated)
Sponsor
Chinese PLA General Hospital · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This study is aimed at verifying the effects of probiotics (KAWAI:dead S.thermophilus) on glucos management among T2DM and pre-diabetes Chinese adult. Additionally, the investigators intend to verify the effects of probiotics on modifying the structure and function of gut microbiome.

Detailed description

Methods: double-blind, randomized controlled trial. Number of participants: 160 patients with pre-diabetes and 60 diabetes. Intervention time: 3months. Data and Specimen collection time: at baseline and after the intervention. Observation index 1. Physical measurement: gender, age, weight, BMI, waist circumference, hip circumference, waist-to-hip ratio, systolic pressure, diastolic blood pressure. 2. Lifestyle questionnaire: diet, drinking, exercise, sleep and other habits. 3. Blood test: blood glucose, OGTT, blood lipid, TNF-a, il-6, il-10, LPS, glp-1, gut microbiome metabolism products, T2DM related methylation. 4\. Gut microbiome detection: gut microbiome 16Sr DNA sequencing, gut microbiome bioinformatics analysis

Conditions

Interventions

TypeNameDescription
BIOLOGICALprobioticsthe probiotics group was taking probiotics 4 packets a day
BIOLOGICALplacebothe placebo group was taking placebo 4 packets a day

Timeline

Start date
2017-12-21
Primary completion
2018-12-31
Completion
2019-08-31
First posted
2017-12-19
Last updated
2017-12-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03377946. Inclusion in this directory is not an endorsement.